药物基因组学门将服务作为药剂师补偿和基于实践的学习机会
Suzanne Lifer-Surowiec1, Jason W Guy2, Julie H Oestreich3
1Mayo Clinic Health System, Eau Claire, WI, USA.
American journal of pharmaceutical education
|November 4, 2024
概括
一个试点的药物基因组学护理服务证明了可行性,参与者表现出对药剂师咨询的兴趣和愿意支付费用. 该计划还为药学学生提供了宝贵的基于实践的学习机会.
科学领域:
- 药物基因组学 药物基因组学
- 药房实践 在药房实践.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 药物基因组学提供了个性化的医学见解,但缺乏广泛的临床整合.
- 门店服务是提供专业药房护理的新型模式.
- 将学生的学习融入到新的服务模式中,对于药房教育至关重要.
研究的目的:
- 为了评估试点药物基因组学护理服务的可行性.
- 评估患者对此类服务的兴趣和支付意愿.
- 为药学学生提供基于实践的学习体验.
主要方法:
- 一项试点研究涉及34名参与者,他们完成了一项关于支付意愿的调查.
- 六名非常感兴趣的参与者获得了免费的礼宾服务,包括基因检测.
- 一个分层的学习模式使高级学生更容易指导初级学生.
主要成果:
- 大多数参与者 (83%) 接受了药物基因组咨询.
- 参与者表示愿意每月支付25至50美元,以继续获得药剂师的服务.
- 患者对该服务的兴趣很高 (平均评分为8.6/10),但如果保险不支付费用,则会下降.
结论:
- 试点项目突出了在实施药物基因组学护理服务方面的成功和挑战.
- 调查结果可以为新药店服务的发展和学生体验式学习机会提供信息.
- 需要进一步的研究来优化将药物基因组学整合到药房实践中的模型.
更多相关视频
相关概念视频
Analysis of Population Pharmacokinetic Data
235
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
235
Biopharmaceutics and Pharmacokinetics: Overview
1.9K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.9K
Pharmacokinetic Models: Overview
597
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
597
Pharmacovigilance
776
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
776
Pharmacokinetics: Overview
5.6K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
5.6K
Nonlinear Pharmacokinetics: Overview
285
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
285


